Neogen Co. (NASDAQ:NEOG) Stock Holdings Lessened by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lessened its holdings in shares of Neogen Co. (NASDAQ:NEOG) by 9.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 37,117 shares of the company’s stock after selling 4,028 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Neogen were worth $746,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of NEOG. SG Americas Securities LLC bought a new position in shares of Neogen during the third quarter valued at approximately $1,017,000. Handelsbanken Fonder AB grew its stake in Neogen by 29.4% during the 3rd quarter. Handelsbanken Fonder AB now owns 39,564 shares of the company’s stock worth $734,000 after buying an additional 9,000 shares during the last quarter. New York State Teachers Retirement System increased its position in Neogen by 29.1% in the third quarter. New York State Teachers Retirement System now owns 126,506 shares of the company’s stock worth $2,345,000 after buying an additional 28,507 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in Neogen by 4.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 98,392 shares of the company’s stock valued at $1,824,000 after buying an additional 4,136 shares during the last quarter. Finally, Advisor Partners II LLC boosted its holdings in shares of Neogen by 6.0% during the third quarter. Advisor Partners II LLC now owns 19,622 shares of the company’s stock valued at $364,000 after acquiring an additional 1,109 shares during the period. Institutional investors and hedge funds own 96.73% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Piper Sandler dropped their price objective on shares of Neogen from $19.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday, April 15th.

Insider Activity

In other news, CFO David H. Naemura bought 12,500 shares of the firm’s stock in a transaction that occurred on Wednesday, April 10th. The stock was acquired at an average price of $12.51 per share, with a total value of $156,375.00. Following the completion of the purchase, the chief financial officer now directly owns 30,040 shares of the company’s stock, valued at approximately $375,800.40. The acquisition was disclosed in a filing with the SEC, which is available at this link. In other Neogen news, CFO David H. Naemura purchased 12,500 shares of the business’s stock in a transaction on Wednesday, April 10th. The stock was bought at an average cost of $12.51 per share, with a total value of $156,375.00. Following the acquisition, the chief financial officer now owns 30,040 shares of the company’s stock, valued at $375,800.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Douglas Edward Jones bought 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 17th. The shares were acquired at an average cost of $12.36 per share, with a total value of $123,600.00. Following the completion of the purchase, the chief operating officer now owns 46,131 shares of the company’s stock, valued at $570,179.16. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 53,000 shares of company stock worth $662,205. 0.71% of the stock is owned by company insiders.

Neogen Stock Up 2.3 %

Shares of Neogen stock opened at $12.42 on Tuesday. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.82 and a quick ratio of 2.66. Neogen Co. has a 1-year low of $11.46 and a 1-year high of $24.09. The business’s fifty day moving average price is $14.81 and its two-hundred day moving average price is $16.32. The company has a market capitalization of $2.69 billion, a P/E ratio of 1,243.24 and a beta of 1.13.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings data on Tuesday, April 9th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.02). Neogen had a net margin of 0.17% and a return on equity of 3.35%. The company had revenue of $228.80 million for the quarter, compared to the consensus estimate of $230.01 million. During the same quarter in the prior year, the firm earned $0.12 earnings per share. Neogen’s revenue for the quarter was up 4.8% compared to the same quarter last year. As a group, research analysts forecast that Neogen Co. will post 0.5 EPS for the current year.

Neogen Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.